FAQs

At CutKilo, we offer expert-led support combined with clinically proven weight loss medication to help you succeed—without judgment, restriction, or overwhelm. You’ll be guided by a dedicated medical team and your own personal health coach, who’s available daily via chat and video. Whether you need motivation, practical advice, or just someone to listen, we’re here every step of the way. With CutKilo, small, realistic changes lead to lasting weight loss—free from food noise and fad diets.

CutKilo is a fully online, doctor-led weight loss service. All consultations, prescriptions, and medical reviews are conducted remotely, allowing you to access care from the comfort of your home with ongoing clinical support.

If you specifically require an in-person appointment, this can be arranged by request at 86 Harley Street, London, W1G 7HP, where Dr Emil Gadimali maintains his private medical practice.

This treatment is suitable for most adults with a BMI of 30 or above, or 27 and above if they have weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnoea. However, it may not be appropriate for everyone.

At CutKilo, every patient undergoes a thorough medical assessment to ensure the treatment is safe and clinically appropriate. It is not recommended for people who are pregnant, breastfeeding, or have a history of certain medical conditions, such as pancreatitis or thyroid cancer.

The CutKilo programme costs £300 per month and includes everything you need for safe, sustainable weight loss:

• Ongoing medical supervision
• Prescription weight loss medication (if clinically appropriate)
• Daily support from your personal health coach via WhatsApp, phone, or video
• Expert guidance from doctors, dieticians, and our wider health team
• No hidden fees and no long-term contracts—you can cancel anytime

We recommend a minimum commitment of 6 months to give your body time to respond and achieve safe, meaningful weight loss. However, you’re free to cancel at any time. For best and most sustainable results, many patients continue for 12 to 18 months. The total duration varies depending on your goals, progress, and how well you respond to treatment. Your doctor will personalise and adjust the plan along the way to support your success.

Mounjaro is a weekly injectable medication. It contains the active ingredient Tirzepatide – a synthetic peptide composed of 39 amino acids.

Tirzepatide is near 90% identical to two naturally occurring hormones in your body, GLP-1 and GIP. It works in your body to keep you feeling full for longer and lower your appetite. It also lowers your risk for cardiovascular disease and diabetes by reducing blood pressure, cholesterol and blood sugar.

Mounjaro comes in the form of a pre-filled injection pen with 4 doses that you administer yourself once a week.

At present, Mounjaro (tirzepatide) is not routinely available on the NHS for weight loss. While the NHS may offer weight management treatments to eligible individuals under specific guidelines, access to newer medications like Mounjaro can be limited and subject to NHS England’s approval processes and NICE guidance.

CutKilo offers private access to Mounjaro under the supervision of a GMC-registered doctor, allowing patients to begin treatment without NHS referral or long waiting times. Our service is ideal for those seeking timely, tailored support on their weight loss journey

Clinical data shows that 96% of patients on the 10mg dose of Mounjaro achieve a weight loss of over 5% of their body weight. On average, patients lose around 16% of their body weight with the 5mg dose, and up to 21.4% with the 10mg dose.

At CutKilo, we typically recommend gradually increasing to the 10mg dose to maximise results while minimising side effects. However, your treatment plan will be carefully tailored to your individual response and tolerance.

Clinical studies have shown that approximately 75% of the weight lost with treatment is body fat, while around 25% may come from lean muscle mass.
In a sub-study of SURMOUNT-1 using DEXA scans, tirzepatide treatment led to significantly greater loss of fat mass than lean mass, resulting in improved body composition compared to placebo after 72 weeks. Most weight loss came from fat — including visceral fat — with a fat-to-muscle loss ratio of approximately 3:1.

To help preserve muscle, it is important to follow a high-protein diet and engage in regular resistance or weight training as part of your weight loss journey.

Tirzepatide is generally well-tolerated, but like all medications, it can cause side effects. The most commonly reported effects are gastrointestinal, especially during the first few weeks of treatment or when increasing the dose. Severe side effects are rare but important to be aware of.

Common side effects (typically within the first 4–6 weeks):

• Nausea – the most frequently reported symptom, affecting up to 50% of patients
• Diarrhoea
• Vomiting
• Decreased appetite
• Constipation
• Abdominal cramps

These effects often appear during dose escalation and usually resolve within about a week.

Less common but more serious side effects:

• • Pancreatitis (inflammation of the pancreas): rare but potentially serious, occurring in approximately 2–3 out of 1,000 patients
  • Gallbladder inflammation: a known risk with most weight loss methods, including bariatric surgery, seen in fewer than 3 in 1,000 patients
  • Allergic reactions: very rare, but may range from mild skin rashes to severe reactions such as anaphylaxis

The first drug in this class of medications was approved back in 2005. So, we actually have more than 19 years of data on these drugs. Over the 19 years, the long-term effects of these medications are that they reduce the risk of developing diabetes by 90%, they reduce the risk of heart attacks by 20%, and we’ve recently learned they’ve reduced the risk of chronic kidney failure by 25%. So, those are the long-term effects! Specifically Mounjaro (Tirzepatide) was tested on thousands of patients in the clinical trials SURMOUNT and proven to be safe and effective.

Currently, there are no general recommendations for blood tests – such as checking liver values – in connection with Mounjaro treatment, unless the patient has a history of liver problems or similar past medical history.

The main risks of weight loss medication affecting the liver are gallstones and pancreatitis, occurring in 2 patients out of 1,000, but blood tests are only necessary if symptoms arise. Blood tests cannot be used to predict whether you as a patient will develop these conditions.

In accordance with good clinical practice, the purpose of any examination, including blood tests, should be carefully considered before it is performed. Since routine blood tests in connection with Mounjaro treatment have no direct consequences for the course of treatment, we do not consider them necessary, in line with the current guidelines from NICE.

While the medication will help you to 20-25% of bodyweight, maintaining the weight loss effectively requires fundamental lifestyle changes. The best way to achieve this is with the dedicated and personal support of our health experts led by our dieticians and nutritionists. At CutKilo, we stress the importance of combining weight loss medication with a strong focus on lifestyle changes, as we do not support the use of medication without this critical component.

Wegovy® and Ozempic® share the same active ingredient – semaglutide. Semaglutide mimics the GLP-1 hormone which is released when we eat. Semaglutide helps the body make insulin and makes you feel full, very much similar to Tirzepatide. Where Tirzepatide acts on GLP1 and GIP (gastric inhibitory peptide) receptors, showing higher effectiveness and better side effect profile reported by the patients. Additionally, Mounjaro (Tirzepatide) has a higher response rate to treatment of 96% (at 10mg dose) (Source: surmount-1 trial), than Wegovy at 86% (taking the maximum 2.4mg dose)
(Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265765/)
We prefer to offer only the best-in-class treatment based on our team’s extensive research of the current treatments available, as well as the pipeline formulations going through extensive clinical trials.

At CutKilo, staying connected is easy. You can reach us via WhatsApp, telephone, or video call. Whether you need to speak with a doctor, dietician, or another healthcare professional, we’ll make sure you’re connected to the right person for the support you need.

Weight regain is possible after stopping treatment, as with any weight loss approach. For some patients, ongoing or even lifelong treatment may be necessary to maintain results, especially if underlying metabolic factors are present.

However, the risk of regaining weight can be significantly reduced by adopting long-term lifestyle changes, including healthy eating habits, regular physical activity, and continued support.